Associations between maternal iron supplementation in pregnancy and offspring growth and cardiometabolic risk outcomes in infancy and childhood.
View / Open Files
Publication Date
2022Journal Title
PLoS One
ISSN
1932-6203
Publisher
Public Library of Science (PLoS)
Volume
17
Issue
5
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Petry, C. J., Olga, L., Hughes, I. A., & Ong, K. K. (2022). Associations between maternal iron supplementation in pregnancy and offspring growth and cardiometabolic risk outcomes in infancy and childhood.. PLoS One, 17 (5) https://doi.org/10.1371/journal.pone.0263148
Description
Funder: NIHR BioResource
Abstract
It was previously observed that maternal iron supplementation in pregnancy was associated with increased offspring size and adiposity at birth, possibly mediated through increased risk of gestational diabetes. In this study we investigated potential long-term associations of maternal iron supplementation in pregnancy with offspring growth in infancy, and growth and cardiometabolic risk factors in mid-childhood to seek evidence of nutritional programming. Using a nested case-control format, markers of growth and adiposity were measured at 3, 12 and 24 months of age in 341 infants from the Cambridge Baby Growth Study whose mothers supplemented with iron in pregnancy and 222 infants whose mothers did not. Measures of growth, glucose tolerance (using a 30 minute 1.75 g glucose/kg body weight oral glucose tolerance test), insulin sensitivity (HOMA IR) and blood pressure were collected in 122 and 79 of these children, respectively, at around 9.5 years of age. In infancy adiposity-promoting associations with maternal iron supplementation in pregnancy were evident at 3 months of age (e.g. mean difference in skinfold thickness: β = +0.15 mm, p = 0.02, in n = 341 whose mothers supplemented versus 222 that did not; waist circumference: β = +0.7 cm, p = 0.04, in n = 159 and 78, respectively) but differences lessened after this time (e.g. 3-12 month change in mean difference in skinfold thickness: β = -0.2 mm, p = 0.03, in n = 272 and 178, respectively). At ~9.5 years of age children whose mothers supplemented with iron in pregnancy had lower mean arterial blood pressures (β = -1.0 mmHg, p = 0.03, in n = 119 and 78, respectively). There were no apparent differences in markers of growth or other cardiometabolic factors. These results suggest that most of the associations of maternal iron supplementation in pregnancy on growth and adiposity evident at birth disappear during infancy, but there may be some evidence of long-term nutritional programming of blood pressure in mid-childhood.
Keywords
Cardiovascular Diseases, Child, Dietary Supplements, Female, Glucose, Humans, Infant, Infant, Newborn, Iron, Mothers, Obesity, Pregnancy
Relationships
Is supplemented by: https://doi.org/10.17863/CAM.79743
Sponsorship
This analysis was funded by the Medical Research Council (7500001180, G1001995, U106179472); the European Union Framework 5 (QLK4-1999-01422); the Newlife Foundation for Disabled Children (07/20); the World Cancer Research Fund International (2004/03) and the Mothercare Charitable Foundation (RG54608). We also acknowledge support from National Institute for Health Research Cambridge Biomedical Research Centre. KKO is supported by the Medical Research Council (Unit Programme numbers: MC_UU_12015/2 and MC_UU_00006/2).
Funder references
National Institute for Health Research (NIHR) (unknown)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Medical Research Council (G1001995)
Medical Research Council (MC_UU_12015/2)
MRC (MC_UU_00006/2)
Medical Research Council (MC_U106179472)
Identifiers
35622831, PMC9140278
External DOI: https://doi.org/10.1371/journal.pone.0263148
This record's URL: https://www.repository.cam.ac.uk/handle/1810/338541
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk